Homo sapiens Protein: OCA2
Summary
InnateDB Protein IDBP-4431.7
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol OCA2
Protein Name oculocutaneous albinism II
Synonyms BEY; BEY1; BEY2; BOCA; D15S12; EYCL; EYCL2; EYCL3; HCL3; P; PED; SHEP1;
Species Homo sapiens
Ensembl Protein ENSP00000261276
InnateDB Gene IDBG-4427 (OCA2)
Protein Structure
UniProt Annotation
Function Could be involved in the transport of tyrosine, the precursor to melanin synthesis, within the melanocyte. Regulates the pH of melanosome and the melanosome maturation. One of the components of the mammalian pigmentary system. Seems to regulate the post-translational processing of tyrosinase, which catalyzes the limiting reaction in melanin synthesis. May serve as a key control point at which ethnic skin color variation is determined. Major determinant of brown and/or blue eye color. {ECO:0000269PubMed:11310796, ECO:0000269PubMed:15262401, ECO:0000269PubMed:18252222, ECO:0000269PubMed:22234890, ECO:0000269PubMed:7601462}.
Subcellular Localization Melanosome membrane {ECO:0000269PubMed:7601462}; Multi-pass membrane protein {ECO:0000269PubMed:7601462}.
Disease Associations Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]: An autosomal recessive disorder in which the biosynthesis of melanin pigment is reduced in skin, hair, and eyes. Although affected infants may appear at birth to have complete absence of melanin pigment, most patients acquire small amounts of pigment with age. Visual anomalies include decreased acuity and nystagmus. The phenotype is highly variable. The hair of affected individuals may turn darker with age, and pigmented nevi or freckles may be seen. African and African American individuals may have yellow hair and blue-gray or hazel irides. One phenotypic variant, 'brown OCA,' has been described in African and African American populations and is characterized by light brown hair and skin color and gray to tan irides. {ECO:0000269PubMed:10649493, ECO:0000269PubMed:10671067, ECO:0000269PubMed:10987646, ECO:0000269PubMed:12713581, ECO:0000269PubMed:12727022, ECO:0000269PubMed:12876664, ECO:0000269PubMed:17385796, ECO:0000269PubMed:7762554, ECO:0000269PubMed:7874125, ECO:0000269PubMed:9259203}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 1 experimentally validated interaction(s) in this database.
Experimentally validated
Total 1 [view]
Protein-Protein 1 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Gene Ontology

Molecular Function
Accession GO Term
GO:0005215 transporter activity
GO:0005302 L-tyrosine transmembrane transporter activity
GO:0005515 protein binding
GO:0015105 arsenite transmembrane transporter activity
Biological Process
GO:0006726 eye pigment biosynthetic process
GO:0006814 sodium ion transport
GO:0015700 arsenite transport
GO:0015828 tyrosine transport
GO:0055085 transmembrane transport
Cellular Component
GO:0005737 cytoplasm
GO:0005765 lysosomal membrane
GO:0005789 endoplasmic reticulum membrane
GO:0010008 endosome membrane
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0033162 melanosome membrane
Protein Structure and Domains
PDB ID
InterPro IPR000802 Arsenical pump membrane protein, ArsB
IPR001898 Sodium/sulphate symporter
IPR004680 Citrate transporter-like domain
PFAM PF02040
PF00939
PF03600
PRINTS PR00758
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q04671
PhosphoSite PhosphoSite-Q04671
TrEMBL C9JDV3
UniProt Splice Variant
Entrez Gene 4948
UniGene Hs.654411
RefSeq NP_001287913
HUGO HGNC:8101
OMIM 611409
CCDS CCDS73701
HPRD 01945
IMGT
EMBL AC079090 AC090696 AC124091 AC135329 BC012097 M97901 M99564 U19153 U19154 U19155 U19156 U19157 U19158 U19159 U19160 U19161 U19162 U19163 U19164 U19165 U19166 U19167 U19168 U19169 U19170 U19171 U19172 U19173 U19174 U19175 U19176
GenPept AAA36430 AAA36477 AAC13783 AAC13784 AAH12097